1. Home
  2. RLMD vs BWMX Comparison

RLMD vs BWMX Comparison

Compare RLMD & BWMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Relmada Therapeutics Inc.

RLMD

Relmada Therapeutics Inc.

HOLD

Current Price

$5.93

Market Cap

661.9M

Sector

Health Care

ML Signal

HOLD

Logo Betterware de Mexico S.A.P.I. de C.V.

BWMX

Betterware de Mexico S.A.P.I. de C.V.

HOLD

Current Price

$18.21

Market Cap

644.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
RLMD
BWMX
Founded
2004
1995
Country
United States
Mexico
Employees
17
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Catalog/Specialty Distribution
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
661.9M
644.3M
IPO Year
2012
2019

Fundamental Metrics

Financial Performance
Metric
RLMD
BWMX
Price
$5.93
$18.21
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
3
Target Price
$12.40
$27.83
AVG Volume (30 Days)
925.0K
68.1K
Earning Date
05-08-2026
04-23-2026
Dividend Yield
N/A
9.11%
EPS Growth
45.28
N/A
EPS
N/A
N/A
Revenue
$13,070.00
N/A
Revenue This Year
N/A
$18.17
Revenue Next Year
N/A
$25.68
P/E Ratio
N/A
$12.54
Revenue Growth
154.83
N/A
52 Week Low
$0.52
$7.80
52 Week High
$8.00
$19.79

Technical Indicators

Market Signals
Indicator
RLMD
BWMX
Relative Strength Index (RSI) 32.00 60.72
Support Level $5.68 $16.04
Resistance Level $7.46 $19.43
Average True Range (ATR) 0.41 0.67
MACD -0.14 0.21
Stochastic Oscillator 5.11 66.76

Price Performance

Historical Comparison
RLMD
BWMX

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.

About BWMX Betterware de Mexico S.A.P.I. de C.V.

Betterware de Mexico SAPI de CV is a company in the consumer product goods industry focused on home organization and beauty and personal care products, commercialized through person-to-person selling. The Group operates through two segments: Home organization under the Betterware brand, including kitchen and food preservation, home solutions, bathroom, laundry & cleaning, tech and mobility, bedroom and wellness. Products are sold through catalogues and distributed through distributors and associates. The Beauty and personal care (B&PC) segment under the JAFRA brand, which generates maximum revenue, includes fragrance, color, skin care and toiletries, distributed through leaders and consultants. The Group operates in Mexico, which generates maximum revenue, the United States and Latam.

Share on Social Networks: